Sublingual Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Allergy is the harmful immune reaction produced by the body to a specific substance or allergen such as dust, pollen, mite, and food. Treatment of allergy generally consists of use of anti-allergy drugs and immunotherapy. These anti-allergy drugs or immunotherapy treatment reduces the allergic reaction caused due to an allergen by decreasing its sensitivity. Immunotherapy has become the most prominent treatment for various allergic diseases in the past few years. Immunotherapy acts by curing the root cause of allergy. This therapy effectively controls and manages the clinical symptoms, reduces or eliminates the need for medication, prevents the worsening of a disease, and reduces the degree of specific and nonspecific bronchial hyperactivity. Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the two types of immunotherapy. Acceptance of immunotherapy is rising in developed as well as developing countries owing to its positive results.
Sublingual immunotherapy exposes a patient to an allergic substance or an allergen repeatedly over a period of time to induce tolerance against that allergic substance. An allergen in the form of drops or a tablet is placed under the tongue. This therapy has been extensively used in Europe for the past 20 years to treat various allergies. Sublingual immunotherapy has several benefits. A major benefit is less risk of severe reactions to tablets or drops as compared to injections. Additionally, once the doctor has administered the first dose of SLIT, the patient can take the further doses by self at home. No more visits to the doctor or medical clinic are required for administration of the dose. Moreover, this therapy is simple, safe, and highly effective in treating allergies. These benefits are anticipated to boost the growth of the global sublingual immunotherapy market during the forecast period.
Sublingual immunotherapy, or allergy shots, is a long-term treatment for allergic disease such as allergic asthma, allergic rhinitis, allergic conjunctivitis (eye allergy), or insect allergy. Immunotherapy is a next generation treatment for allergy and it can modify the natural course of a disease. Increase in prevalence of allergies is a key driver of the global sublingual immunotherapy market. In 2015, prevalence of allergic diseases globally was estimated to be 20% to 30% of the world’s population, which is about 1 billion people suffering from some kind of allergies. Allergic rhinitis affects most of the population across the world. According to the World Allergy Organization (WAO), about 400 million people worldwide are affected by allergic rhinitis. Sublingual immunotherapy therapy is highly used in the treatment of allergic rhinitis. Increase in environmental pollution contributes to the growth of the sublingual immunotherapy market.
The global sublingual immunotherapy market can be segmented based on product type, distribution channel, and region. In terms of product type, the market can be categorized into drops and tablets. The U.S. Food Drug and Administration (FDA) has approved three allergy tablet products: Oralair, Grastek, and Ragwitek. Currently, there are no FDA-approved liquid drops available in the market. This provides an opportunity for pharmaceutical companies to invest and gain a foothold in the global sublingual immunotherapy drops market. Based on distribution channel, the market can be classified into hospital pharmacies, retail pharmacies and drug stores, and online pharmacies.
In terms of region, the global sublingual immunotherapy market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the global market because of fast growing life science industry, rise in focus on research & new drug development, and increase in the number of pharmaceutical companies focusing on immunotherapy. Europe is the second largest market for sublingual immunotherapy. Most of the immunotherapy drugs are approved in Europe and adoption of the therapy is likely to increase rapidly during the forecast period. Asia Pacific is projected to be the most lucrative market for sublingual immunotherapy and is expected to expand at the highest growth rate from 2017 to 2025. Rise in government initiatives, grants, and funds; increase in life science R&D spending, especially in India, China, and Japan, and dedicated research commercial zones are attracting domestic and foreign players to invest and enter the lucrative research sector in Asia Pacific.
Key players operating in the global sublingual immunotherapy market include Allergon AB (Thermo Fisher Scientific, Inc.), HAL Allergy Group, Allergy Therapeutics, Stallergenes Greer, and ALK.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017